B2C (Greece – Cyprus)
_____________________
RAFARM is a pharmaceutical industry with an important role and dynamic commercial activity in the domestic market (Greece and Cyprus). Our sales are increasing with a rapid pace and are a strong strategic pillar for sustainable growth. Furthermore, we expand our local product portfolio with products from Top pharmaceutical companies.
Our clear business plan, the prompt adaptation to the new era of the pharmaceutical industry, the rapid market penetration and the trust of the health professionals make RAFARM a trusted partner.
We achieve results
B2C in Greece
150 sales
& marketing highly qualified professionals
15% growth rate in domestic market for the last 10 years
21 new
promoted products
the last 3 years
14 new
product launches
until 2024
150 sales
& marketing highly qualified professionals
15% growth rate in domestic market for the last 10 years
21 new
promoted products
the last 3 years
14 new
product launches
until 2024
In licensing partnerships
